We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Effectiveness Study of Pramlintide to Treat Post-Transplant Diabetes Mellitus

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01165944
Recruitment Status : Withdrawn
First Posted : July 20, 2010
Last Update Posted : October 3, 2012
Amylin Pharmaceuticals, LLC.
Information provided by (Responsible Party):
University of Colorado, Denver

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : August 2011
  Estimated Study Completion Date : August 2011